{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T15:20:47Z","timestamp":1783351247626,"version":"3.54.6"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12887-018-1365-7","type":"journal-article","created":{"date-parts":[[2018,12,12]],"date-time":"2018-12-12T08:28:38Z","timestamp":1544603318000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["A case of incomplete Kawasaki disease with extremely high serum ferritin and interleukin-18 levels"],"prefix":"10.1186","volume":"18","author":[{"given":"Takanori","family":"Noto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Seto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junji","family":"Fukuhara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masao","family":"Murabayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Yachie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamoru","family":"Ayusawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5685-2670","authenticated-orcid":false,"given":"Ichiro","family":"Morioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,12,12]]},"reference":[{"key":"1365_CR1","doi-asserted-by":"publisher","first-page":"e927","DOI":"10.1161\/CIR.0000000000000484","volume":"135","author":"BW McCrindle","year":"2017","unstructured":"McCrindle BW, Rowley AH, Newburger JW, Burns JC, Bolger AF, Gewitz M, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation. 2017;135:e927\u201399.","journal-title":"Circulation"},{"key":"1365_CR2","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.jpeds.2008.10.006","volume":"154","author":"AL Baker","year":"2009","unstructured":"Baker AL, Lu M, Minich LL, Atz AM, Klein GL, Korsin R, et al. Associated symptoms in the ten days before diagnosis of Kawasaki disease. J Pediatr. 2009;154:592\u20135.","journal-title":"J Pediatr"},{"key":"1365_CR3","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/j.jpeds.2006.01.039","volume":"148","author":"GW Gong","year":"2006","unstructured":"Gong GW, McCrindle BW, Ching JC, Yeung RS. Arthritis presenting during the acute phase of Kawasaki disease. J Pediatr. 2006;148:800\u20135.","journal-title":"J Pediatr"},{"key":"1365_CR4","first-page":"145","volume":"13","author":"EP \u00c1lvarez","year":"2017","unstructured":"\u00c1lvarez EP, Rey F, Pe\u00f1a SC, Rubio A, Calvo C, Collado P. Has articular involvement lessened in Kawasaki disease? Rheumatol Clin. 2017;13:145\u20139.","journal-title":"Rheumatol Clin"},{"key":"1365_CR5","first-page":"229","volume":"10","author":"A Stabile","year":"2006","unstructured":"Stabile A, Avallone L, Compagnone A, Ansuini V, Bertoni B, Rigante D. Focus on juvenile idiopathic arthritis according to the 2001 revised Edmonton classification from the international league of associations for rheumatology. Eur Rev Med Pharmacol Sci. 2006;10:229\u201334.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"1365_CR6","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1093\/rheumatology\/keq133","volume":"49","author":"M Shimizu","year":"2010","unstructured":"Shimizu M, Yokoyama T, Yamada K, Kaneda H, Wada H, Wada T, et al. Distinct cytokine profiles of systemic-onset juvenile idiopathic arthritis-associated macrophage activation syndrome with particular emphasis on the role of interleukin-18 in its pathogenesis. Rheumatology. 2010;49:1645\u201353.","journal-title":"Rheumatology"},{"key":"1365_CR7","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s00296-014-3059-2","volume":"35","author":"T Takahara","year":"2015","unstructured":"Takahara T, Shimizu M, Nakagishi Y, Kinjo N, Yachie A. Serum IL-18 as a potential specific marker for differentiating systemic juvenile idiopathic arthritis from incomplete Kawasaki disease. Rheumatol Int. 2015;35:81\u20134.","journal-title":"Rheumatol Int"},{"key":"1365_CR8","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1590\/1414-431x20165958","volume":"50","author":"Y Xia","year":"2017","unstructured":"Xia Y, Cui P, Li Q, Liang F, Li C, Yang J. Extremely elevated IL-18 levels may help distinguish systemic-onset juvenile idiopathic arthritis from other febrile diseases. Braz J Med Biol Res. 2017;50:1414\u201331.","journal-title":"Braz J Med Biol Res"},{"key":"1365_CR9","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1159\/000080660","volume":"135","author":"Y Nomura","year":"2004","unstructured":"Nomura Y, Masuda K, Maeno N, Yoshinaga M, Kawano Y. Serum levels of interleukin-18 are elevated in the subacute phase of Kawasaki syndrome. Int Arch Allergy Immunol. 2004;135:161\u20135.","journal-title":"Int Arch Allergy Immunol"},{"key":"1365_CR10","doi-asserted-by":"publisher","first-page":"2539","DOI":"10.1002\/art.10389","volume":"46","author":"N Maeno","year":"2002","unstructured":"Maeno N, Takei S, Nomura Y, Imanaka H, Hokonohara M, Miyata K. Highly elevated serum levels of interleukin-18 in systemic juvenile idiopathic arthritis but not in other juvenile idiopathic arthritis subtypes or in Kawasaki disease. Arthritis Rheum. 2002;46:2539\u201341.","journal-title":"Arthritis Rheum"},{"key":"1365_CR11","doi-asserted-by":"publisher","first-page":"929","DOI":"10.3109\/14397595.2016.1159120","volume":"26","author":"M Mizuta","year":"2016","unstructured":"Mizuta M, Shimizu M, Inoue N, Kasai K, Nakagishi Y, Takahara T, et al. Serum ferritin levels as useful diagnostic marker for the distinction of systemic juvenile idiopathic arthritis and Kawasaki disease. Mod Rheumatol. 2016;26:929\u201332.","journal-title":"Mod Rheumatol"},{"key":"1365_CR12","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1016\/S0140-6736(11)61930-2","volume":"379","author":"T Kobayashi","year":"2012","unstructured":"Kobayashi T, Saji T, Otani T, et al. Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE sturdy) : a randomized, open-label, blined-endpoints trial. Lancet. 2012;379:1613\u201320.","journal-title":"Lancet"},{"key":"1365_CR13","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s00296-009-0960-1","volume":"30","author":"D Rigante","year":"2010","unstructured":"Rigante D, Valentini P, Onesimo R, Angelone DF, De Nisco A, Bersani G, et al. Incomplete Kawasaki syndrome followed by systemic onset juvenile idiopathic arthritis mimicking Kawasaki syndrome. Rheumatol Int. 2010;30:535\u20139.","journal-title":"Rheumatol Int"},{"key":"1365_CR14","first-page":"390","volume":"31","author":"RE Petty","year":"2004","unstructured":"Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, et al. International league of associations for rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol. 2004;31:390\u20132.","journal-title":"J Rheumatol"},{"key":"1365_CR15","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.jcma.2013.04.005","volume":"76","author":"KP Wang","year":"2013","unstructured":"Wang KP, Hsieh KS, Huang SH, Ou SF, Lai TJ, Tang CW, et al. Interleukin-18 and coronary artery lesions in patients with Kawasaki disease. J Chin Med Assoc. 2013;76:438\u201345.","journal-title":"J Chin Med Assoc"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-018-1365-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12887-018-1365-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-018-1365-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,11]],"date-time":"2019-12-11T19:16:57Z","timestamp":1576091817000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpediatr.biomedcentral.com\/articles\/10.1186\/s12887-018-1365-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1365"],"URL":"https:\/\/doi.org\/10.1186\/s12887-018-1365-7","relation":{},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"4 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethics approval was obtained from the ethics committee in Numazu City Hospital (approval number 2018\u20130008). The patient\u2019s guardian provided the written informed consent to participate.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"We obtained the written consent for publication from the guardian of the patient.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors have no conflicts of interest to declare for this work. Outside the submitted work, I.M. has received grants from Japan Blood Product Organization, Daiichi Sankyo Co., Ltd., MSD Co., Ltd., AbbVie LLC, Taisho Toyama Pharmaceutical Co., Ltd., and Air Water Inc.; lecture fees from MSD Co., Ltd., Pfizer Japan, Inc., Novo Nordisk Pharma Ltd., Shionogi Co., Ltd., AbbVie LLC, Japan Vaccine Co., Ltd., Asahikasei Medical Co., Ltd., and Atom Medical Corp.; manuscript fees from Atom Medical Corp., Sanofi K.K., Asahikasei Medical Co., Ltd., and Japan Blood Product Organization,; and honoraria from Sanofi K.K.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"386"}}